Tokyo, Aug. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058718) titled 'Efficacy of Comprehensive Therapy, Including Pharmacotherapy and Dietary/Lifestyle Guidance, on Renoprotection in Patients with Chronic Kidney Disease' on Aug. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Nihon University
Condition:
Condition - Chronic Kidney Disease (CKD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate whether newly approved drugs, administered as monotherapy or in combination, demonstrate an effect in preventing the progression of CKD. Furthermore, this study will examine if the addition of dietary and lifestyle guidance enhances this suppressive effect. We will also assess whether the efficacy of these treatments can be confirmed in patients with advanced-stage CKD, a population typically excluded from previous clinical trials.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with CKD at our institution, as well as those who were diagnosed at a previous institution and subsequently referred to us.
Key exclusion criteria - 1, Individuals judged by the principal investigator to be unsuitable for the study.
2. Individuals who decline to participate in this study.
Target Size - 500
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 05 Month 01 Day
Date of IRB - 2025 Year 04 Month 30 Day
Anticipated trial start date - 2025 Year 05 Month 01 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067142
Disclaimer: Curated by HT Syndication.
